$SEER

Seer schedules Aug. 11 webcast for second-quarter results

Seer, Inc. (Nasdaq: SEER) said it will release its second-quarter 2026 financial results on Tuesday, Aug. 11, 2026. Management will host a webcasted conference call at 1:30 p.m. Pacific (4:30 p.m. Eastern), with live audio and a replay on Seer’s investor website. The article also notes prior earnings-date price reactions.

Original reporting
Published Aug 3, 2026, 8:05 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 4, 2026, 2:25 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$SEER
Neutral
medium confidence
Mentioned
$SEER
Relevance
5/10
alphai data visualization · based on stocktitan.net
Decision brief

The 30-second read

$SEERNeutralMed
01

Why it matters

The primary impact is scheduling. Traders can plan event-driven exposure around the earnings release and the 4:30 p.m. ET webcast, but there is no new guidance, contract, or regulatory development in the text.

02

Market read

This sets a concrete earnings catalyst date for SEER, supporting event-driven positioning and volatility expectations into Aug. 11.

03

What to watch

The body mentions prior insider net selling and prior earnings-date price reactions, but it does not provide fresh insider transactions or new results, so those signals may already be priced.

Relevance 5/10Novelty 5/10Timing: ahead of Aug. 11 pre-market/after-market Q2 results and 4:30 p.m. ET webcast

Background

Seer, Inc. (Nasdaq: SEER) announced it will report Q2 2026 financial results on Tuesday, Aug. 11, 2026, with a management webcasted conference call.

Company-level read

Ticker impact

$SEERNeutralMedium confidence
Context

Seer schedules its Q2 2026 results for Aug. 11 and will host a webcasted call at 4:30 p.m. ET, setting a clear earnings catalyst date.

Expected impact

Likely elevated pre-earnings volatility; direction depends on Q2 results and any updated outlook.

Evidence & confidence

The article discloses the reporting date, webcast time, and replay availability, but provides no Q2 numbers, guidance, or new operational/regulatory developments.

Market effects

Limited sector read-through because the article contains no proteomics-industry datapoints beyond Seer’s own earnings timing.

Minimal, as it is a single-company earnings scheduling notice with no macro/regional policy content.

Low, no international deal, regulator action, or cross-border operational change is mentioned.

Counterpoint

Because the article contains no new financial figures or guidance, traders may treat it as already-known calendar noise and focus only on the actual Aug. 11 release.

Key entities

  • Seer, Inc.

    Nasdaq-listed proteomics company scheduling Q2 2026 results and a webcasted earnings call.

  • Investor webcast

    Live audio and later replay available on Seer’s investor website starting at 1:30 p.m. PT / 4:30 p.m. ET on Aug. 11.

Related articles

$SEERMedAI 8/10

Two Revised, Non-Binding Proposals Seek to Acquire All of Seer's Class A Shares

Seer Confirms Receipt of Further Revised Unsolicited Acquisition Proposals From Radoff-JEC Group and From Omid Farokhzad, M.D. Rhea-AI Summary Seer (Nasdaq: SEER) confirmed receipt of two further revised, unsolicited, non-binding acquisition proposals for all outstanding shares of its Class A common stock. On July 28, 2026, the Radoff-JEC Group offered $2.55 per share in cash plus a contingent value right.

$SEERMed

Seer Stock Surges 40% After Investor Presentation Highlights AI, Growth Strategy

Seer, Inc. (SEER) shares rose about 39.8% to $2.27 on Monday after the company published an investor presentation ahead of its July 28 annual meeting. Seer cited an AI-driven proteomics strategy, commercialization progress, an expanding installed base, strategic collaborations, about $220M cash with no debt, and a stated $23B proteomics market opportunity by 2034, and urged shareholders to reject activist proposals.

$SEERMed

Seer Shares Rally 30% Following Investor Update Ahead of Annual Meeting (SEER)

Seer, Inc. (NASDAQ:SEER) shares rose about 30% after the company filed an investor presentation ahead of its July 28, 2026 annual meeting. Seer cited a $23B proteomics TAM by 2034, 62% CAGR growth in installed customers since 2021, 36% lower annual cash burn since 2022, ~$220M cash and no debt, and a $50M buyback authorization. A proxy contest is ongoing.